Polyurethanes

Natural and Synthetic Biomedical Polymers

Volumn , Issue , 2014, Pages 123-144

  Shelke, Namdev B ^a   Nagarale, Rajaram K ^b   Kumbar, Sangamesh G ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

Composite polyurethanes; Degradation; Drug delivery; Poly(carbonate urethanes); Poly(ester urethanes); Poly(ether urethane)s; Poly(siloxane urethanes); Polyurethanes; Surface modified polyurethanes; Tissue engineering

Indexed keywords

EID: 84902935799     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-396983-5.00007-7     Document Type: Chapter

References (155)

1. Lamba N.M.K., Woodhouse K.A., Cooper S.L. Polyurethanes in Biomedical Applications Boca Raton 1998, CRC Press, New York.
2. Li Z., Zhang Z., Liu K., Ni X., Li J. Biodegradable hyperbranched amphiphilic polyurethane multiblock copolymers consisting of poly(propylene glycol), poly(ethylene glycol), and polycaprolactone as in situ thermogels. Biomacromolecules 2012, 13(12):3977-3989.
3. Lijuan Z., Lunquan Y., Mingming D., Jiehua L., Hong T., Zhigao W., Qiang F. Synthesis and characterization of pH-sensitive biodegradable polyurethane for potential drug delivery applications. Macromolecules 2011, 44:857-864.
4. Mattu C., Pabari R., Boffito M., Sartori S., Ciardelli G., Ramtoola Z. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells. Eur. J. Pharm. Biopharm. 2013, 85(3):463-472.
5. Gupta K., Pearce S., Poursaid A., Aliyar H., Tresco P., Mitchnik M., Kiser P. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. J. Pharm. Sci. 2008, 97(10):4228-4239.
6. S.H. Kuo, P. Kuzma, Long term drug delivery devices with polyurethane based polymers and their manufacture, US8343528 B2, US 12/907,717, 2013.
7. Shelke N., Clark J., Johnson T., Fabian J., Tuitupou A., Nebeker J., Clark M., Friend D., Kiser P. 90 Day vaginal delivery of poorly water soluble drug levonorgestrel from coaxially extruded polyurethane reservoirs 2011.
8. Grad S., Kupcsik L., Gorna K., Gogolewski S., Alini M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Biomaterials 2003, 24(28):5163-5171.
9. Williamson M.R., Black R., Kielty C. PCL-PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cells. Biomaterials 2006, 27(19):3608-3616.
10. Shirota T., He H., Yasui H., Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng. 2003, 9(1):127-136.
11. Santerre J., Labow R., Adams G. Re: the polyurethane foam covering the Même Breast Prosthesis: a biomedical breakthrough or a biomaterial tar baby?. Ann. Plast. Surg. 1992, 29(5):477-478.
12. Zdrahala R., Zdrahala I. Biomedical applications of polyurethanes: a review of past promises, present realities, and a vibrant future. J. Biomater. Appl. 1999, 14(1):67-90.
13. Martin D., Warren L., Gunatillake P., McCarthy S., Meijs G., Schindhelm K. Polydimethylsiloxane/polyether-mixed macrodiol-based polyurethane elastomers: biostability. Biomaterials 2000, 21(10):1021-1029.
14. Woo G., Mittelman M., Santerre J. Synthesis and characterization of a novel biodegradable antimicrobial polymer. Biomaterials 2000, 21(12):1235-1246.
15. Ma Z., Hong Y., Nelson D., Pichamuthu J., Leeson C., Wagner W. Biodegradable polyurethane ureas with variable polyester or polycarbonate soft segments: effects of crystallinity, molecular weight, and composition on mechanical properties. Biomacromolecules 2011, 12(9):3265-3274.
16. Skarja G., Woodhouse K. Synthesis and characterization of degradable polyurethane elastomers containing and amino acid-based chain extender. J. Biomater. Sci. Polym. Ed. 1998, 9(3):271-295.
17. Guan J., Sacks M., Beckman E., Wagner W. Biodegradable poly(ether ester urethane)urea elastomers based on poly(ether ester) triblock copolymers and putrescine: synthesis, characterization and cytocompatibility. Biomaterials 2004, 25(1):85-96.
18. Park J., Park K., Bae Y. PDMS-based polyurethanes with MPEG grafts: synthesis, characterization and platelet adhesion study. Biomaterials 1999, 20(10):943-953.
19. Lin Y.H., Chou N.K., Chen K.F., Ho G.H., Chang C.H., Wang S.S., Chu S.H., Hsieh K.H. Effect of soft segment length on properties of hydrophilic/hydrophobic polyurethanes. Polym. Int. 2007, 56:1415-1422.
20. Guelcher S. Biodegradable polyurethanes: synthesis and applications in regenerative medicine. Tissue Eng. B Rev. 2008, 14(1):3-17.
21. Bonzani I., Adhikari R., Houshyar S., Mayadunne R., Gunatillake P., Stevens M. Synthesis of two-component injectable polyurethanes for bone tissue engineering. Biomaterials 2007, 28(3):423-433.
22. David E., Derek M., Mauro A. Degradation of synthetic polymeric scaffolds for bone and cartilage tissue repairs. Soft Matter 2009, 5:938-947.
23. S. Gogolewski, Biocompatible, biodegradable polyurethane materials with controlled hydrophobic to hydrophilic ratio, EP Patent App. 20, PCT/CH2004/000471, WO/2006/010278.
24. Sheth J.P., Aneja A., Wilkes G.L., Yilgor E., Atilla G.E., Yilgor I., Beyer F.L. Influence of system variables on the morphological and dynamic mechanical behavior of polydimethylsiloxane based segmented polyurethane and polyurea copolymers: a comparative perspective. Polymer 2004, 45(20):6919-6932.
25. Ho E., Damian F., Tuitupou A., Shelke N., Clark M., Friend F., Kiser P. A combination intravaginal ring for the protection against HIV and unwanted pregnancy 2010.
26. Guan J., Fujimoto K., Sacks M., Wagner W. Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. Biomaterials 2005, 26(18):3961-3971.
27. Sin D., Miao X., Liu G., Wei F., Chadwick G., Yan C., Friis T. Polyurethane (PU) scaffolds prepared by solvent casting/particulate leaching (SCPL) combined with centrifugation. Mater. Sci. Eng. C 2010, 30(1):78-85.
28. Agarwal S., Wendorff J., Greiner A. Use of electrospinning technique for biomedical applications. Polymer 2008, 49(26):5603-5621.
29. Nirmala R., Kang H.S., El-Newehy M., Navamathavan R., Park H.M., Kim H. Human osteoblast cytotoxicity study of electrospun polyurethane/calcium chloride ultrafine nanofibers. J. Nanosci. Nanotechnol. 2011, 11(6):4749-4756.
30. Machado H., Correia R., Covas J. Synthesis, extrusion and rheological behaviour of PU/HA composites for biomedical applications. J. Mater. Sci. Mater. Med. 2010, 21(7):2057-2066.
31. Santerre J., Woodhouse K., Laroche G., Labow R. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials. Biomaterials 2005, 26(35):7457-7470.
32. Mathur A., Collier T., Kao W., Wiggins M., Schubert M., Hiltner A., Anderson J. In vivo biocompatibility and biostability of modified polyurethanes. J. Biomed. Mater. Res. 1997, 36(2):246-257.
33. Gorna K., Gogolewski S. Biodegradable polyurethanes for implants. II. In vitro degradation and calcification of materials from poly(epsilon-caprolactone)-poly(ethylene oxide) diols and various chain extenders. J. Biomed. Mater. Res. 2002, 60(4):592-606.
34. van Tienen T., Heijkants R., Buma P., de Groot J., Pennings A., Veth R. Tissue ingrowth and degradation of two biodegradable porous polymers with different porosities and pore sizes. Biomaterials 2002, 23(8):1731-1738.
35. Gunatillake P.A., Martin D.J., Meijs G.F., McCarthy S.J., Adhikari R. Designing biostable polyurethane elastomers for biomedical implants. Aust. J. Chem. 2003, 56(6):545-557.
36. Simmons A., Hyvarinen J., Odell R., Martin D., Gunatillake P., Noble K., Poole-Warren L. Long-term in vivo biostability of poly(dimethylsiloxane)/poly(hexamethylene oxide) mixed macrodiol-based polyurethane elastomers. Biomaterials 2004, 25(20):4887-4900.
37. Christenson E., Dadsetan M., Wiggins M., Anderson J., Hiltner A. Poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo studies. J. Biomed. Mater. Res. A 2004, 69(3):407-416.
38. Nakajima-Kambe T., Shigeno-Akutsu Y., Nomura N., Onuma F., Nakahara T. Microbial degradation of polyurethane, polyester polyurethanes and polyether polyurethanes. Appl. Microbiol. Biotechnol. 1999, 51(2):134-140.
39. Fujimoto K., Inoue H., Ikada Y. Protein adsorption and platelet adhesion onto polyurethane grafted with methoxy-poly(ethylene glycol) methacrylate by plasma technique. J. Biomed. Mater. Res. 1993, 27(12):1559-1567.
40. Fujimoto K., Tadokoro H., Ueda Y., Ikada Y. Polyurethane surface modification by graft polymerization of acrylamide for reduced protein adsorption and platelet adhesion. Biomaterials 1993, 14(6):442-448.
41. S. Kuo, P. Kuzma, Long term drug delivery devicew with polyurethane based polymers and their manufacture, US Patent 20130096496, 13/693659, Endo Pharmaceuticals Soulutions, Inc., 2013.
42. P. Kuzma, H. Quandt, Long term drug delivery devices with polyurethane-based polymers and their manufacture, US Patent 8,460,274, 2013.
43. S.H. Kuo, P. Kuzma, Long term drug delivery devices with polyurethane based polymers and their manufacture, Google Patents, 2013.
44. P. Kiser, T. Johnson, J. Clark, N. Shelke, R. Rastogi, Intravaginal devices for drug delivery, in WO Patent App. PCT/US2012/047649, WO/2013/013172, University of Utah, Salt Lake City, Utah, 2012.
45. G. Elliott, C. Gilligan, C. Lorimer, Intravaginal reservoir drug delivery devices, WO Patent App. PCT/EP2003/003, EP1494646A1, EP1494646B1, US20050042292, WO2003080018A1, Grant Elliott, Galen (Chemicals) Limited, Claire Gilligan, Colin Lorimer, 2003.
46. S. Nabahi, Intravaginal drug delivery device, EP Patent App. 19, USP # 5,788,980, 1998.
47. C. Gilligan, C. Passmore, Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors, WO Patent App. PCT/IE1998/000, 1998.
48. R. Zimmerman, P. Burck, R. Dunn, Contraceptive device, US4469671 A, US 06/468,436, Eli Lilly And Company,1984.
49. K. Kamath, J. Barry, H. Sepideh, Polymeric coatings for controlled delivery of active agents, US 6,335,029 B1, Scimed Life Systems, Inc., Maple grove, MN (US), 2002.
50. R.J. Zdrahala, I.J. Zdrahala, In vivo tissue engineering with biodegradable polymers, Google Patents, 2002.
51. W. Easterbrook III, L. Gudis, M. Howansky, H. Levin, P. Michelman, R. Reinhardt, C. Sherman, J. Tsitlik, N. Ziselson, Method and apparatus for assisting a heart to pump blood, Google Patents, Cardio Technologies, Inc., 2001.
52. E. Brady, A. Cannon, F. Farrell, G. Mccaffrey, A tissue engineering scaffold, WO Patent App. PCT/IE2000/000059, 2000.
53. H. Nita, L.P. Jansen, P. Park, G. Samson, E. Engelson, J. Sarge, Optimized high performance multiple coil spiral-wound vascular catheter, Google Patents, Target Therpeutics, Inc., Fremont, Calif., USA, 1999.
54. P. Zilla, D. Bezuidenhout, Porous synthetic vascular grafts with oriented ingrowth channels, WO Patent App. PCT/US1999/027, Medtronic, Inc., 1999.
55. R.J. Tuch, Blood contacting medical device and method, Google Patents, Medtronic, Inc., 1999.
56. R.V. Snyders, Ventricular assist device, Google Patents, 1987.
57. M. Szycher, Extrudable polyurethane for prosthetic devices prepared from a diisocyanate, a polytetramethylene ether polyol, and 1, 4-butane diol, Google Patents, 1985.
58. M. Szycher, Process for forming an optically clear polyurethane lens or cornea, Google Patents, 1983.
59. M. Szycher, Polyurethane elastomer for heart assist devices, Google Patents, 1978.
60. Shelke N.B., Aminabhavi T.M. Synthesis and characterization of methoxypolyethyleneglycol and lauric acid grafted novel polyurethanes for controlled release of nifedipine. J. Appl. Polym. Sci. 2007, 105:2155-2163.
61. Shelke N., Sairam M., Halligudi S., Aminabhavi T.M. Development of transdermal drug delivery films with castoroil based polyurethanes. J. Appl. Polym. Sci. 2007, 103(2):779-788.
62. Cohn D., Stern T., González M., Epstein J. Biodegradable poly(ethylene oxide)/poly(epsilon-caprolactone) multiblock copolymers. J. Biomed. Mater. Res. 2002, 59(2):273-281.
63. Sathiskumar P., Madras G. Synthesis, characterization, degradation of biodegradable castor oil based polyesters. Polym. Degrad. Stab. 2011, 96(9):1695-1704.
64. Pissis P., Kanapitsas A., Savelyev Y.V., Akhranovich E., Privalko E., Privalko V. Influence of chain extenders and chain end groups on properties of segmented polyurethanes. II. Dielectric study. Polymer 1998, 39(15):3431-3435.
65. Adhikari R., Gunatillake P.A., Mccarthy S.J., Meijs G.F. Effect of chain extender structure on the properties and morphology of polyurethanes based on H12MDI and mixed macrodiols (PDMS-PHMO). J. Appl. Polym. Sci. 1999, 74(12):2979-2989.
66. Simmons A., Padsalgikar A., Ferris L., Poole-Warren L. Biostability and biological performance of a PDMS-based polyurethane for controlled drug release. Biomaterials 2008, 29(20):2987-2995.
67. Thomas V., Jayabalan M. A new generation of high flex life polyurethane urea for polymer heart valve-studies on in vivo biocompatibility and biodurability. J. Biomed. Mater. Res. A 2009, 89(1):192-205.
68. González-Paz R., Lligadas G., Ronda J., Galià M., Ferreira A., Boccafoschi F., Ciardelli G., Cádiz V. Study on the interaction between gelatin and polyurethanes derived from fatty acids. J. Biomed. Mater. Res. A 2013, 101(4):1036-1046.
69. Obruca S., Marova I., Vojtova L. Biodegradation of polyether-polyol-based polyurethane elastomeric films: influence of partial replacement of polyether polyol by biopolymers of renewable origin. Environ. Technol. 2011, 32(9-10):1043-1052.
70. Chan-Chan L., Solis-Correa R., Vargas-Coronado R., Cervantes-Uc J., Cauich-Rodríguez J., Quintana P., Bartolo-Pérez P. Degradation studies on segmented polyurethanes prepared with HMDI, PCL and different chain extenders. Acta Biomater. 2010, 6(6):2035-2044.
71. Trovati G., Sanches E.A., Neto S.C., Mascarenhas Y.P., Chierice G.O. Characterization of polyurethane resins by FTIR, TGA, and XRD. J. Appl. Polym. Sci. 2010, 115:263-268.
72. Widjaja L., Kong J., Chattopadhyay S., Lipik V., Liow S., Abadie M., Venkatraman S. Triblock copolymers of ε-caprolactone, trimethylene carbonate, and L-lactide: effects of using random copolymer as hard-block. J. Mech. Behav. Biomed. Mater. 2012, 6:80-88.
73. Fu S.Z., Meng X.H., Fan J., Yang L.L., Lin S., Wen Q.L., Wang B.Q., Chen L.L., Wu J.B., Chen Y. In vitro and in vivo degradation behavior of n-HA/PCL-Pluronic-PCL polyurethane composites. J. Biomed. Mater. Res. A 2014, 102(2):479-486.
74. McCarthy S., Meijs G., Mitchell N., Gunatillake P., Heath G., Brandwood A., Schindhelm K. In-vivo degradation of polyurethanes: transmission-FTIR microscopic characterization of polyurethanes sectioned by cryomicrotomy. Biomaterials 1997, 18(21):1387-1409.
75. Senich G.A., MacKnight W.J. Fourier transform Infrared thermal analysis of a segmented polyurethane. Macromolecules 1980, 13(1):106-110.
76. Bajsic E.G., Rek V. DSC study of morphological changes in segmented polyurethane elastomers. J. Elastom. Plast. 2000, 32(2):162-182.
77. Pergal M., Antić V., Tovilović G., Nestorov J., Vasiljević-Radović D., Djonlagić J. In vitro biocompatibility evaluation of novel urethane-siloxane co-polymers based on poly(e-caprolactone)-block-poly(dimethylsiloxane)-block-poly(e-caprolactone). J. Biomater. Sci. Polym. Ed. 2012, 23(13):1629-1657.
78. Sawant S., Selvaraj V., Prabhawathi V., Doble M. Antibiofilm properties of silver and gold incorporated PU, PCLm, PC and PMMA nanocomposites under two shear conditions. PLoS one 2013, 8(5):1-9. e63311.
79. Sarkar D., Yang J.C., Gupta A., Lopina S. Synthesis and characterization of L-tyrosine based polyurethanes for biomaterial applications. J. Biomed. Mater. Res. A 2009, 90(1):263-271.
80. Frost M., Meyerhoff M. Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiol-derivatized fumed silica polymer filler particles. J. Biomed. Mater. Res. A 2005, 72(4):409-419.
81. Khan O., Sefton M. Endothelialized biomaterials for tissue engineering applications in vivo. Trends Biotechnol. 2011, 29(8):379-387.
82. McGuigan A., Sefton M. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 2007, 28(16):2547-2571.
83. Planck H., Egbers G., Syre I. Polyurethanes in Biomedical Engineering 1984, Elsevier Science Publishers B.V., Amsterdam.
84. Stokes K.B., Urbanski P.W., Davis M.W., Coury A.J. Pacemaker leads. Nine Years Experience with Polyurethane Leads 1985, 279-286. Elsevier Science Publishers, Amsterdam, The Netherlands. A.E. Aubert, H. Ector (Eds.).
85. Stokes K., McVenes R., Anderson J.M. Polyurethane elastomer biostability. J. Biomater. Appl. 1995, 9:321-354.
86. Chan-Chan L., Tkaczyk C., Vargas-Coronado R., Cervantes-Uc J., Tabrizian M., Cauich-Rodriguez J. Characterization and biocompatibility studies of new degradable poly(urea)urethanes prepared with arginine, glycine or aspartic acid as chain extenders. J. Mater. Sci. Mater. Med. 2013, 24(7):1733-1744.
87. Grasl C., Bergmeister H., Stoiber M., Schima H., Weigel G. Electrospun polyurethane vascular grafts: in vitro mechanical behavior and endothelial adhesion molecule expression. J. Biomed. Mater. Res. A 2010, 93(2):716-723.
88. Brandwood A., Meijs G.F., Gunatillake P.A., Noble K.R., Shindhelm K., Rizzardo E. In vivo evaluation of polyurethanes based on novel macrodiols and MDI. J. Biomater. Sci. Polym. Ed. 1994, 6(1):41-54.
89. Takahara A., Coury A.J., Hergenrother R.W., Cooper S.L. Effect of soft segment chemistry on the biostability of segmented polyurethanes. I. In vitro oxidation. J. Biomed. Mater. Res. 1991, 25:341-356.
90. Zhao Q., McNally A., Rubin K., Renier M., Wu Y., Rose-Caprara V., Anderson J., Hiltner A., Urbanski P., Stokes K. Human plasma alpha 2-macroglobulin promotes in vitro oxidative stress cracking of Pellethane 2363-80A: in vivo and in vitro correlations. J. Biomed. Mater. Res. 1993, 27(3):379-388.
91. Christenson E., Patel S., Anderson J., Hiltner A. Enzymatic degradation of poly(ether urethane) and poly(carbonate urethane) by cholesterol esterase. Biomaterials 2006, 27(21):3920-3926.
92. Tang Y., Labow R., Santerre J. Enzyme induced biodegradation of polycarbonate-polyurethanes: dose dependence effect of cholesterol esterase. Biomaterials 2003, 24(12):2003-2011.
93. Yi H., Jianjun G., Kazuro L.F., Ryotaro H., Anca L.P., William R.W. Tailoring the degradation kinetics of poly(ester carbonate urethane)urea thermoplastic elastomers for tissue engineering scaffolds. Biomaterials 2010, 31(15):4249-4258.
94. Christenson E., Anderson J., Hiltner A. Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo and in vitro correlations. J. Biomed. Mater. Res. A 2004, 70(2):245-255.
95. Tanzi M., Farè S., Petrini P. In vitro stability of polyether and polycarbonate urethanes. J. Biomater. Appl. 2000, 14(4):325-348.
96. Gorna K., Gogolewski S. In vitro degradation of novel medical biodegradable aliphatic polyurethanes based on -caprolactone and Pluronics® with various hydrophilicities. Polym. Degrad. Stab. 2002, 75(1):113-122.
97. Roohpour N., Wasikiewicz J., Paul D., Vadgama P., Rehman I. Synthesis and characterisation of enhanced barrier polyurethane for encapsulation of implantable medical devices. J. Mater. Sci. Mater. Med. 2009, 20(9):1803-1814.
98. Soldani G., Losi P., Bernabei M., Burchielli S., Chiappino D., Kull S., Briganti E., Spiller D. Long term performance of small-diameter vascular grafts made of a poly(ether)urethane-polydimethylsiloxane semi-interpenetrating polymeric network. Biomaterials 2010, 31(9):2592-2605.
99. Briganti E., Al Kayal T., Kull S., Losi P., Spiller D., Tonlorenzi S., Berti D., Soldani G. The effect of gamma irradiation on physical-mechanical properties and cytotoxicity of polyurethane-polydimethylsiloxane microfibrillar vascular grafts. J. Mater. Sci. Mater. Med. 2010, 21(4):1311-1319.
100. Hernandez R., Weksler J., Padsalgikar A., Runt J. In vitro oxidation of high polydimethylsiloxane content biomedical polyurethanes: correlation with the microstructure. J. Biomed. Mater. Res. A 2008, 87(2):546-556.
101. Xu F., Nacker J., Crone W., Masters K. The haemocompatibility of polyurethane-hyaluronic acid copolymers. Biomaterials 2008, 29(2):150-160.
102. Macocinschi D., Filip M., Butnaru C., Dimitriu C.D. Surface characterization of biopolyurethanes based on cellulose derivatives. J. Mater. Sci. Mater. Med. 2009, 20:775-783.
103. Macocinschi D., Filip D., Vlad S., Cristea M., Butnaru M. Segmented polyurethanes for medical applications. J. Mater. Sci. Mater. Med. 2009, 20:1659-1668.
104. Macocinschi D., Filip D., Vlad S. Surface and mechanical properties of some new biopolyurethane composites. Polym. Compos. 2010, 31:1956-1964.
105. Moldovan L., Craciunescu O., Zarnescu O., Macocinschi D., Bojin D. Preparation and characterization of new biocompatibilized polymeric materials for medical use. J. Optoelectron. Adv. Mater. 2008, 10(4):942.
106. Yoshii T., Dumas J., Okawa A., Spengler D., Guelcher S. Synthesis, characterization of calcium phosphates/polyurethane composites for weight-bearing implants. J. Biomed. Mater. Res. B Appl. Biomater. 2012, 100(1):32-40.
107. Li Z., Yao S.J., Alini M., Stoddart M. Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites is modulated by frequency and amplitude of dynamic compression and shear stress. Tissue Eng. A 2010, 16(2):575-584.
108. Sask K., Berry L., Chan A., Brash J. Polyurethane modified with an antithrombin-heparin complex via polyethylene oxide linker/spacers: influence of PEO molecular weight and PEO-ATH bond on catalytic and direct anticoagulant functions. J. Biomed. Mater. Res. A 2012, 100(10):2821-2828.
109. Sask K., Berry L., Chan A., Brash J. Modification of polyurethane surface with an antithrombin-heparin complex for blood contact: influence of molecular weight of polyethylene oxide used as a linker/spacer. Langmuir 2012, 28(4):2099-2106.
110. Schmidt C., Bezuidenhout D., Higham L., Zilla P., Davies N. Induced chronic hypoxia negates the pro-angiogenic effect of surface immobilized heparin in a polyurethane porous scaffold. J. Biomed. Mater. Res. A 2011, 98(4):621-628.
111. Shen Z., Kang C., Chen J., Ye D., Qiu S., Guo S., Zhu Y. Surface modification of polyurethane towards promoting the ex vivo cytocompatibility and in vivo biocompatibility for hypopharyngeal tissue engineering. J. Biomater. Appl. 2013, 28(4):607-616.
112. Williams R., Krishna Y., Dixon S., Haridas A., Grierson I., Sheridan C. Polyurethanes as potential substrates for sub-retinal retinal pigment epithelial cell transplantation. J. Mater. Sci. Mater. Med. 2005, 16(12):1087-1092.
113. Lehle K., Stock M., Schmid T., Schopka S., Straub R., Schmid C. Cell-type specific evaluation of biocompatibility of commercially available polyurethanes. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 90(1):312-318.
114. Wu W., Sask K., Brash J., Selvaganapathy P. Polyurethane-based microfluidic devices for blood contacting applications. Lab Chip 2012, 12(5):960-970.
115. Petrović Z.S., Ferguson J., Hudson N., Javni I., Vraneš M. The effect of hard segment structure on rheological properties of solutions of segmented polyurethanes. Eur. Polym. J. 1992, 28(6):637-642.
116. Ma C., Hou Y., Liu S., Zhang G. Effect of microphase separation on the protein resistance of a polymeric surface. Langmuir 2009, 25(16):9467-9472.
117. Xu L.C., Siedlecki C. Microphase separation structure influences protein interactions with poly(urethane urea) surfaces. J. Biomed. Mater. Res. A 2010, 92(1):126-136.
118. Feng L., Andrade J.D. Structure and adsorption properties of fibrinogen. ACS Sym. Ser.#602 1995, 66-79. American Chemical Society, Washington, DC. T.A. Horbett, J.L. Brash (Eds.).
119. Brunstedt M.R., Ziats N.P., Schubert M., Hiltner P.A., Anderson J.M. Protein adsorption onto poly(ether urethane ureas) containing methacrol 2138F: a surface-active amphiphilic additive. J. Biomed. Mater. Res. 1993, 27:255-267.
120. Chu S.H., Hung C.R., Yang Y.J. Comparison of long term results of various card iac valvular prostheses. Biologic and Bioprosthetic Valves 1984, 805-816. Yorke Medical Books, New York. E. Bod nar, M. Yacoub (Eds.).
121. Garcia-Bengochea J.B., Casagrande I., Gonzalez-Juanatey J.R., Puig L., Rubio J., Duran D., Sierra J. The new Labcor-Santiago pericardial bioprosthesis. J. Card. Surg. 1991, 6:613-619.
122. Herold M., Lo H.B., Reul H., et al. The Helmholtz-Institute tri-leaflet-polyurethane-heart valve prosthesis: design, manufacturing and first in-vitro and in-vivo results. Polyurethanes in Biomedical Engineering, vol. II 1987, 231-256. Elsevier Science, Amsterdam. H. Planck, I. Syre, M. Dauner, G. Egbers (Eds.).
123. Nistal F., Garcia-Martinez V., Arbe E., Fernandez D., Mazzora F., Gallo I. In vivo experimental assessment of polytetrafluoroethylene trileaflet heart valve prosthesis. J. Thorac. Cardiovasc. Surg. 1990, 99:1074-1081.
124. Jansen J., Reul H. A synthetic three-leaflet valve. J. Med. Eng. Technol. 1992, 16:27-33.
125. Khan I., Smith N., Jones E., Finch D., Cameron R. Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part I: materials selection and evaluation. Biomaterials 2005, 26(6):621-631.
126. Gogolewski S. Nonmetallic materials for bone substitute. Eur. Cells Mater. 2001, 1:54-55.
127. Gorna K., Gogolewski S. Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes. J. Biomed. Mater. Res. A 2003, 67(3):813-827.
128. Guo Q., Knight P.T., Mather P.T. Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes. J. Control. Release 2009, 137:224-233.
129. Kim J., Kim S., Lee S., Lee C., Kim D. The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix. Int. J. Pharm. 2000, 201(1):29-36.
130. Li B., Brown K., Wenke J., Guelcher S. Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model. J. Control. Release 2010, 145(3):221-230.
131. Moura S., Lima L., Andrade S., Da Silva-Cunha A., Órefice R., Ayres E., Da Silva G. Local drug delivery system: inhibition of inflammatory angiogenesis in a murine sponge model by dexamethasone-loaded polyurethane implants. J. Pharm. Sci. 2011, 100(7):2886-2895.
132. Pinto F., Da Silva-Cunha A., Oréfice R., Ayres E., Andrade S., Lima L., Moura S., Da Silva G. Controlled release of triamcinolone acetonide from polyurethane implantable devices: application for inhibition of inflammatory-angiogenesis. J. Mater. Sci. Mater. Med. 2012, 23(6):1431-1445.
133. Nelson D., Baraniak P., Ma Z., Guan J., Mason N., Wagner W. Controlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold. Pharm. Res. 2011, 28(6):1282-1293.
134. De Campos N.L., de Andrade R.R., Silva M.A. Oral anticoagulation in carriers of mechanical heart valve prostheses: experience of ten years. Rev. Bras. Cir. Cardiovasc. 2010, 25:457-465.
135. Hoffmann G., Lutter G., Cremer J. Durability of bioprosthetic cardiac valves. Dtsch. Arztebl. Int. 2008, 105:143-148.
136. Thierfelder N., Koenig F., Bombien R., Fano C., Reichart B., Wintermantel E., Schmitz C., Akra B. In vitro comparison of novel polyurethane aortic valves and homografts after seeding and conditioning. ASAIO J. 2013, 59(3):309-316.
137. Bergmeister H., Schreiber C., Grasl C., Walter I., Plasenzotti R., Stoiber M., Bernhard D., Schima H. Healing characteristics of electrospun polyurethane grafts with various porosities. Acta Biomater. 2013, 9(4):6032-6040.
138. Bergmeister H., Grasl C., Walter I., Plasenzotti R., Stoiber M., Schreiber C., Losert U., Weigel G., Schima H. Electrospun small- diameter polyurethane vascular grafts: ingrowth and differentiation of vascular-specific host cells. Artif. Organs 2012, 36(1):54-61.
139. Jovanovic D., Engels G., Plantinga J., Bruinsma M., van Oeveren W., Schouten A., van Luyn M., Harmsen M. Novel polyurethanes with interconnected porous structure induce in vivo tissue remodeling and accompanied vascularization. J. Biomed. Mater. Res. A 2010, 95(1):198-208.
140. Hill C.M., An Y.H., Kang Q.K., Hartsock L.A., Gogolewski S., Gorna K. Osteogenesis of osteoblast seeded polyurethane-hydroxyapatite scaffolds in nude mice. Macromol. Symp. 2007, 253(1):94-97.
141. Asefnejad A., Behnamghader A., Khorasani M., Farsadzadeh B. Polyurethane/fluor-hydroxyapatite nanocomposite scaffolds for bone tissue engineering. Part I: morphological, physical, and mechanical characterization. Int. J. Nanomedicine 2011, 6:93-100.
142. Herrmann F., Lehner A., Hollweck T., Haas U., Fano C., Fehrenbach D., Kozlik-Feldmann R., Wintermantel E., Eissner G., Hagl C., Akra B. In vitro biological and mechanical evaluation of various scaffold materials for myocardial tissue engineering. J. Biomed. Mater. Res. A 2013, 10.1002/jbm.a.34786.
143. Rodriguez J., Clubb F., Wilson T., Miller M., Fossum T., Hartman J., Tuzun E., Singhal P., Maitland D. In vivo response to an implanted shape memory polyurethane foam in a porcine aneurysm model. J. Biomed. Mater. Res. A 2013, 10.1002/jbm.a.34782.
144. Korossis S.A., Fisher J., Ingham E. Cardiac valve replacement: a bioengineering approach. Biomed. Mater. Eng. 2000, 10:83-124.
145. Hilbert S.L., Ferrans V.J., Tomita Y., Eidbo E.E., Jones M. Evaluation of explanted polyurethane trileaflet cardiac valve prostheses. J. Thorac. Cardiovasc. Surg. 1987, 94:419-429.
146. Wu L., Weisberg D.M., Runt J., Felder G., Snyder A.J., Rosenberg G. An investigation of the in vivo stability of poly(ether urethaneurea) blood sacs. J. Biomed. Mater. Res. 1999, 11:371-380.
147. Butterfield M., Wheatley D.J., Williams D.F., Fisher J. A new design for polyurethane heart valves. J. Heart Valve Dis. 2001, 10(1):105-110.
148. Thomas V., Jayabalan M. Studies on the effect of virtual crosslinking on the hydrolytic stability of novel aliphatic polyurethane ureas for blood contact applications. J. Biomed. Mater. Res. 2001, 56(1):144-157.
149. Myers K., Sgaglione N., Kurzweil P. A current update on meniscal scaffolds. Oper. Tech. Sports Med. 2013, 21:75-81.
150. Mackay T., Wheatley D., Bernacca G., Fisher A., Hindle C. New polyurethane heart valve prosthesis: design, manufacture and evaluation. Biomaterials 1996, 17(19):1857-1863.
151. Oloffs A., Grosse-Siestrup C., Bisson S., Rinck M., Rudolph R., Gross U. Biocompatibility of silver-coated polyurethane catheters and silver-coated Dacron material. Biomaterials 1994, 15(10):753-758.
152. Moura L.I.F., Dias A.M.A., Carvalhoa E., de Sousa H.C. Recent advances on the development of wound dressings for diabetic foot ulcer treatment-a review. Biomaterialia 2013, 9:7093-7114.
153. Epstein N.E. Do silver-impregnated dressings limit infections after lumbar laminectomy with instrumented fusion?. Surg. Neurol. 2007, 68:483-485.
154. Knuttinen M.G., Bobra S., Hardman J., Gaba R.C., Bui J.T., Owens C.A. Review of evolving dialysis catheter technologies. Semin. Internat. Rad. 2009, 26(2):106-114.
155. Bayer, "Medical device developments", "A hydroselective approach to healing", Baymedix A.